Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) FCF Margin (2016 - 2025)

Cumberland Pharmaceuticals' FCF Margin history spans 16 years, with the latest figure at 0.02% for Q4 2025.

  • For Q4 2025, FCF Margin fell 1821.0% year-over-year to 0.02%; the TTM value through Dec 2025 reached 10.86%, up 1265.0%, while the annual FY2025 figure was 10.86%, 1265.0% up from the prior year.
  • FCF Margin for Q4 2025 was 0.02% at Cumberland Pharmaceuticals, down from 1.97% in the prior quarter.
  • Across five years, FCF Margin topped out at 41.56% in Q4 2022 and bottomed at 25.63% in Q1 2024.
  • The 5-year median for FCF Margin is 5.06% (2024), against an average of 8.36%.
  • The largest annual shift saw FCF Margin tumbled -1835bps in 2022 before it skyrocketed 5851bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 0.53% in 2021, then surged by 8014bps to 41.56% in 2022, then crashed by -140bps to 16.54% in 2023, then skyrocketed by 210bps to 18.23% in 2024, then tumbled by -100bps to 0.02% in 2025.
  • Per Business Quant, the three most recent readings for CPIX's FCF Margin are 0.02% (Q4 2025), 1.97% (Q3 2025), and 7.54% (Q2 2025).